Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models. | Br J Cancer | 2022 | 35318435 | PubTator, text mining | PubMed |
| Cancer vaccines as promising immuno-therapeutics: platforms and current progress. | J Hematol Oncol | 2022 | 35303904 | PubTator, text mining | PubMed |
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
| Messenger RNA vaccines for cancer immunotherapy: progress promotes promise. | J Clin Invest | 2022 | 35289317 | PubTator, text mining | PubMed |
| CAR-T cell therapy for lung cancer: Potential and perspective. | Thorac Cancer | 2022 | 35289077 | PubTator, text mining | PubMed |
| On the Twentieth Anniversary of Dendritic Cell Vaccines - Riding the Next Wave. | Cancer Res | 2022 | 35288731 | PubTator, text mining | PubMed |
| MAGEA1 and hTERT Peptide Treatment Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC Treated Acute Myeloid Leukemia. | J Cancer | 2022 | 35281868 | PubTator, text mining | PubMed |
| When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies. | Front Oncol | 2022 | 35280746 | PubTator, text mining | PubMed |
| A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. | Nat Immunol | 2022 | 35241833 | PubTator, text mining | PubMed |
| Biomarkers of non-communicable chronic disease: an update on contemporary methods. | PeerJ | 2022 | 35233297 | PubTator, text mining | PubMed |
| Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens? | Int J Mol Sci | 2022 | 35216137 | PubTator, text mining | PubMed |
| Identification of Tissue-Specific Gene Clusters Induced by DNA Demethylation in Lung Adenocarcinoma: More Than Germline Genes. | Cancers (Basel) | 2022 | 35205751 | PubTator, text mining | PubMed |
| Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients. | Cancers (Basel) | 2022 | 35205608 | PubTator, text mining | PubMed |
| Immunotherapeutic Approaches for Glioblastoma Treatment. | Biomedicines | 2022 | 35203636 | PubTator, text mining | PubMed |
| Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis. | Curr Oncol | 2022 | 35200574 | PubTator, text mining | PubMed |
| Peptides for Vaccine Development. | ACS Appl Bio Mater | 2022 | 35195008 | PubTator, text mining | PubMed |
| Cancer/Testis Antigen 55 is required for cancer cell proliferation and mitochondrial DNA maintenance. | Mitochondrion | 2022 | 35189384 | PubTator, text mining | PubMed |
| What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination. | Oncoimmunology | 2022 | 35186441 | PubTator, text mining | PubMed |
| Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma. | Blood Adv | 2022 | 35175355 | PubTator, text mining | PubMed |
| Effect of CPAP on blood glucose fluctuation in patients with type 2 diabetes mellitus and obstructive sleep apnea. | Sleep Breath | 2022 | 35165839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=15